Peter Schaffer

Learn More
Teduglutide is a recombinant analogue of human glucagon-like peptide-2 that has recently been approved for the treatment of short bowel syndrome in adults. This study was designed to study the influence of renal function and age on teduglutide pharmacokinetics. This was an open-label study with six parallel groups (6 subjects each). Three groups with renal(More)
Deliverable 1.2 presents simulation details for integrated routing, in-network processing and aggregator node election concepts. These concepts are united under the PLUG-IN (PANEL-LUNAR aggregation and routing for in-network processing). The PLUG-IN architecture provides: An integrated solution for universal routing supporting data centric and address(More)
  • 1